Comparative Efficacy of Botulinum Toxin in Salivary Glands vs. Oromotor Therapy in the Management of Sialorrhea in Cerebral Palsy Impact on Sleep Quality

AimsThe aim of this study was to compare the effects of intraglandular abobotuliniumtoxinA application and oromotor therapy in the management of sialorrhea in patients with cerebral palsy and its effect on sleep quality.MethodsA comparative study (n = 134), mean age 7.1 years (± 3.9 years) was perfo...

Full description

Bibliographic Details
Main Authors: Juan Francisco Marquez-Vazquez, María Elena Arellano-Saldaña, Karla Nayeli Rojas-Martinez, Paul Carrillo-Mora
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Rehabilitation Sciences
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fresc.2022.875235/full
_version_ 1797964781429194752
author Juan Francisco Marquez-Vazquez
María Elena Arellano-Saldaña
Karla Nayeli Rojas-Martinez
Paul Carrillo-Mora
author_facet Juan Francisco Marquez-Vazquez
María Elena Arellano-Saldaña
Karla Nayeli Rojas-Martinez
Paul Carrillo-Mora
author_sort Juan Francisco Marquez-Vazquez
collection DOAJ
description AimsThe aim of this study was to compare the effects of intraglandular abobotuliniumtoxinA application and oromotor therapy in the management of sialorrhea in patients with cerebral palsy and its effect on sleep quality.MethodsA comparative study (n = 134), mean age 7.1 years (± 3.9 years) was performed in pediatric patients, between the efficacy of abobotuliniumtoxinA in salivary glands and oromotor therapy (JT), with a control group receiving exclusive oromotor therapy (EOMT). Demographic variables, as well as Gross Motor Function Classification System (GMFCS), Drooling Severity and Frequency Scale (DSFS), Sleep Disturbance Scale for Children (SDSC) and Eating and Drinking Ability Classification System (EDACS) were analyzed in 134 patients considering two measurements 6 months apart. Statistical analysis was developed between both groups.ResultsThe greatest improvement in safety and efficacy of swallowing were those in the JT group with initial levels of EDACS IV and V. Both therapies result in favorable changes of all subscales means of SDSC, with joint therapy showing the greater benefit (p = 0.003) over EOMT (p = 0.06), especially for Sleep Breathing Disorders and Disorders of initiating and maintaining sleep (p < 0.01 vs. p = 0.07). No major adverse effects were found, only those expected from the application of the toxin, such as pain, mild, and transient local inflammation.InterpretationA correlation between frequency and intensity of sialorrhea, with the frequency of sleep disorders and dysphagia was found. Conventional EOMT proved to be useful, improving the safety and efficacy of swallowing, sialorrhea and sleep disorder, however it can be enhanced with the application of abobotuliniumtoxinA.
first_indexed 2024-04-11T01:50:21Z
format Article
id doaj.art-e401eb1826514512ba18b6900f14b55f
institution Directory Open Access Journal
issn 2673-6861
language English
last_indexed 2024-04-11T01:50:21Z
publishDate 2022-06-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Rehabilitation Sciences
spelling doaj.art-e401eb1826514512ba18b6900f14b55f2023-01-03T06:55:19ZengFrontiers Media S.A.Frontiers in Rehabilitation Sciences2673-68612022-06-01310.3389/fresc.2022.875235875235Comparative Efficacy of Botulinum Toxin in Salivary Glands vs. Oromotor Therapy in the Management of Sialorrhea in Cerebral Palsy Impact on Sleep QualityJuan Francisco Marquez-Vazquez0María Elena Arellano-Saldaña1Karla Nayeli Rojas-Martinez2Paul Carrillo-Mora3Master and Doctorate Division, Instituto Nacional de Rehabilitación LGII, Tlalpan, MéxicoPediatric Rehabilitation Service, Instituto Nacional de Rehabilitación LGII, Tlalpan, MéxicoPediatric Rehabilitation Service, Instituto Nacional de Rehabilitación LGII, Tlalpan, MéxicoNeuroscience Research Division, Instituto Nacional de Rehabilitación LGII, Tlalpan, MéxicoAimsThe aim of this study was to compare the effects of intraglandular abobotuliniumtoxinA application and oromotor therapy in the management of sialorrhea in patients with cerebral palsy and its effect on sleep quality.MethodsA comparative study (n = 134), mean age 7.1 years (± 3.9 years) was performed in pediatric patients, between the efficacy of abobotuliniumtoxinA in salivary glands and oromotor therapy (JT), with a control group receiving exclusive oromotor therapy (EOMT). Demographic variables, as well as Gross Motor Function Classification System (GMFCS), Drooling Severity and Frequency Scale (DSFS), Sleep Disturbance Scale for Children (SDSC) and Eating and Drinking Ability Classification System (EDACS) were analyzed in 134 patients considering two measurements 6 months apart. Statistical analysis was developed between both groups.ResultsThe greatest improvement in safety and efficacy of swallowing were those in the JT group with initial levels of EDACS IV and V. Both therapies result in favorable changes of all subscales means of SDSC, with joint therapy showing the greater benefit (p = 0.003) over EOMT (p = 0.06), especially for Sleep Breathing Disorders and Disorders of initiating and maintaining sleep (p < 0.01 vs. p = 0.07). No major adverse effects were found, only those expected from the application of the toxin, such as pain, mild, and transient local inflammation.InterpretationA correlation between frequency and intensity of sialorrhea, with the frequency of sleep disorders and dysphagia was found. Conventional EOMT proved to be useful, improving the safety and efficacy of swallowing, sialorrhea and sleep disorder, however it can be enhanced with the application of abobotuliniumtoxinA.https://www.frontiersin.org/articles/10.3389/fresc.2022.875235/fullcerebral palsybotulinum toxin type Asleep disorderssialorrheaoromotor assessment
spellingShingle Juan Francisco Marquez-Vazquez
María Elena Arellano-Saldaña
Karla Nayeli Rojas-Martinez
Paul Carrillo-Mora
Comparative Efficacy of Botulinum Toxin in Salivary Glands vs. Oromotor Therapy in the Management of Sialorrhea in Cerebral Palsy Impact on Sleep Quality
Frontiers in Rehabilitation Sciences
cerebral palsy
botulinum toxin type A
sleep disorders
sialorrhea
oromotor assessment
title Comparative Efficacy of Botulinum Toxin in Salivary Glands vs. Oromotor Therapy in the Management of Sialorrhea in Cerebral Palsy Impact on Sleep Quality
title_full Comparative Efficacy of Botulinum Toxin in Salivary Glands vs. Oromotor Therapy in the Management of Sialorrhea in Cerebral Palsy Impact on Sleep Quality
title_fullStr Comparative Efficacy of Botulinum Toxin in Salivary Glands vs. Oromotor Therapy in the Management of Sialorrhea in Cerebral Palsy Impact on Sleep Quality
title_full_unstemmed Comparative Efficacy of Botulinum Toxin in Salivary Glands vs. Oromotor Therapy in the Management of Sialorrhea in Cerebral Palsy Impact on Sleep Quality
title_short Comparative Efficacy of Botulinum Toxin in Salivary Glands vs. Oromotor Therapy in the Management of Sialorrhea in Cerebral Palsy Impact on Sleep Quality
title_sort comparative efficacy of botulinum toxin in salivary glands vs oromotor therapy in the management of sialorrhea in cerebral palsy impact on sleep quality
topic cerebral palsy
botulinum toxin type A
sleep disorders
sialorrhea
oromotor assessment
url https://www.frontiersin.org/articles/10.3389/fresc.2022.875235/full
work_keys_str_mv AT juanfranciscomarquezvazquez comparativeefficacyofbotulinumtoxininsalivaryglandsvsoromotortherapyinthemanagementofsialorrheaincerebralpalsyimpactonsleepquality
AT mariaelenaarellanosaldana comparativeefficacyofbotulinumtoxininsalivaryglandsvsoromotortherapyinthemanagementofsialorrheaincerebralpalsyimpactonsleepquality
AT karlanayelirojasmartinez comparativeefficacyofbotulinumtoxininsalivaryglandsvsoromotortherapyinthemanagementofsialorrheaincerebralpalsyimpactonsleepquality
AT paulcarrillomora comparativeefficacyofbotulinumtoxininsalivaryglandsvsoromotortherapyinthemanagementofsialorrheaincerebralpalsyimpactonsleepquality